There's word today of a broad change in Medicare drug coverage that spells relief for cancer patients but could mean a major new expense for the government.
Medicare is expanding its coverage to allow reimbursement for some so-called "off-label" use of cancer drugs. That is, drugs prescribed in a way not specifically approved by the Food and Drug Administration.
Medicare announced the change in a news release June 5, but it went largely unnoticed until picked up by The New York Times today.
A spokesman for the American Society of Clinical Oncology says the eased reimbursement policy will reduce "the hassle factor."
But because cancer drugs often can cost thousands of dollars a month, the decision is sparking controversy. Consumers Union thinks Medicare should take a second look at the policy. A spokesman says in some cases, there's very small gain but at great cost.
(Copyright 2009 by The Associated Press. All Rights Reserved.)
U.S. Health and Human Services Secretary Kathleen Sebelius reiterated Tuesday that she won’t intervene in the “incredibly agonizing” case involving a 10-year-old Pennsylvania girl who is waiting for a lung transplant, telling members of Congress that medical experts should make those decisions.
One of the first provisions of the 2010 health reform law has had its intended effect: shifting costs from hospitals, taxpayers and families to health insurance companies, researchers reported on Thursday. It’s one of the most popular aspects of the law.
People may realize that fast food isn’t health food, but they don’t realize just how fattening it really is, researchers report. They surveyed people eating at 10 burger, chicken, sandwich and doughnut chains and found they greatly underestimated just how much they were chowing down.
A new line of caffeinated chewing gum is causing jitters among health advocates and prompting federal officials to take a new look at the proliferation of jolt-infused foods, including those marketed to children and teens.